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Abstract 
 
Background: Diabetic foot ulcer is a common surgical complication in patient of diabetes mellitus. It is the most 
frequent reason for hospitalization for patients with diabetes. Still the ideal material for dressing is not known.  This 
study has been conducted to compare the efficacy of topical application of Povidone- Iodine with recombinant 
epidermal growth factor in  chronic diabetic foot ulcers of size 5 to 10 cm2.Methods: Diabetic foot ulcers which 
were non-healing for more than 3 months were  randomized into two groups of 30 each. Clinical examination of the 
ulcer and limb was  done. Ischemic ulcers, ulcers with gangrene or associated osteomyelitis were excluded. One 
group  had received Povidone iodine  (Betadine 10% solution) soaked dressing while other group was dressed with  
Recombinant Epidermal Growth Factor gel (Eugraf 150 mcg gel) dressing  twice weekly for 12 weeks. At the end of 
twelve weeks ulcers were assessed for healing. .Results:There were total 60 cases from Jan 2014 till Dec 2014. Age 
range from 45 to 70 yrs (mean age 55 yrs). There were 45 males and 15 females (M: F:  3:1).  The ulcers were 
developed  most commonly in foot in 48 patients ( 80%) followed by  in lower leg around ankle in 06 patients ( 
10%)  and in 10 % of cases involved foot and leg both.  Six (20%) patients on Povidone- Iodine dressing group 
showed complete wound healing while 23 (76%) patients on recombinant epidermal growth factor dressing group 
showed complete wound healing. Dressing with recombinant epidermal growth factor is the more effective than 
Povidone iodine dressing (P<. 001). Average healing time for complete healing for completely healed ulcers was 11 
weeks in  Povidone-Iodine Dressing and 8 weeks in Recombinant epidermal growth factor  dressing group. 
Conclusion: Recombinant epidermal growth factor dressing is the significantly effective dressing in comparison to 
Povidone-Iodine in diabetic foot  non healing ulcers of size 5 to 10 cm in size. Average time of complete healing of 
diabetic foot  non healing ulcers is less with topical application of Recombinant epidermal growth factor  soaked 
dressing as compared to Povidone – Iodine dressings. 
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Diabetic foot is defined as any inframalleolar wound  
in a person with diabetes mellitus. As different studies 
have showed that the up to 25 % of patient of diabetes 
needs hospitalization due to diabetic foot infections and 
it is the most frequent reason for hospitalization for 
patients with diabetes. Peripheral sensory neuropathy, 
trauma and foot deformity are the most commonly triad 
associated with this disease[1]. The prevalence of 
diabetes worldwide was estimated to be 2.8% in 2000 
and 4.4% in 2030. The total number of patients with 
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diabetes increasing worldwide and estimated to rise 
from 171 million in 2000 to 366 million in 2030 and 
prevalence appears to be the increase in of people 65 
years of age[2]. The prevalence of diabetic foot ulcer is 
4-10% and the risk of developing diabetic foot 
infection during life-time in a diabetic is as high as 
15% to 25%.[3].While 7% to 20% of patients with foot 
ulcers will subsequently require an amputation, foot 
ulceration is the precursor to approximately 85% of 
lower extremity of amputations in persons with 
diabetes. Diabetes continues to be the most common 
underlying cause of nontraumatic lower extremity 
amputations in the India[4]. Survival rates after 
amputation are generally lower for diabetic versus non 
diabetic patients[5] . Major factors responsible for 
DFU and amputation include com-promised blood 
supply due to peripheral micro vascular disease, with 
lack of sensation due to peripheral neuropathy and high 
blood sugar level. Both these factors in turn predispose 
to repetitive trauma and super imposed infection[6]. 
Almost 85% of the amputations are preceded by 
diabetic foot ulcers[7].In this modern era where we  
has started transplanting the body organs but still the 
management of  of chronic wound remains a challenge 
for surgeons especially if associated with diabetes.  
Different types of dressing methods and material are 
available from decades but still the ideal method and 
material for non healing wounds is not known 
especially for diabetic foot infections. This study was 
conducted to compare the efficacy of Povidone iodine  
and Recombinant Epidermal Growth Factor (Eugraf) 
dressing in the treatment of chronic diabetic foot 
ulcers. 
 
Materials and methods  
 
Study design & duration 
This prospective study was conducted in  patients with 
diabetic foot ulcers presenting in OPD or admitted in 
the surgical ward in Rohilkhand Medical College and 
Hospital, Bareilly, U.P. during  Jan 2014 to Dec 2014 
Inclusion criteria 
Diabetic foot  ulcer ( infra malleolar foot ulcers) not 
healing from past three months and size  5 cm to 10 
cm. Only patients with type 2 diabetic mellitus were 
included. 
Exclusion criteria 
Patient presenting to hospital with gangrene of the toes 
or foot. Patients with vascular compromise of lower 
limb vessels documented by Colour Doppler study. 
Patients with osteomyelitis or associated fracture of 
bone on x ray. All patients with septic shock, diabetes 
keto-acidosis or associated serious co-morbidities 
needs emergency care were excluded. 
Assessment and monitoring 
 All the cases included in this study were investigated. 
Complete blood count, random blood sugar, post 
prandial blood sugar, HbA1c, renal function test, 
Colour Doppler of the lower limb for vascular 
evaluation and x-ray of the involved part were done to 
look for any evidence of osteomyelitis or fracture. 
Glycemic control was done by repeated blood sugar 
estimation and HbA1c estimation periodically. Culture 
of all the wounds were done at time of enrollment in 
the study and repeated if required and antibiotics were 
as per culture and sensitivity reports. Ulcers associated 
with dead and necrosed tissue or having pus flakes 
were taken up for wound debridement and wound was 
subsequent debridement was done if necessary as per 
clinical evaluation of the ulcer. The cases were 
randomized into two groups. Group I was given 10 % 
Povidone iodine solution (Betadine 10 % solution from 
Win medicare India) and Group II– Recombinant 
Epidermal Growth Factor (rEGF) (Eugraf from Lupin 
India, 150 mcg in 15 gm tube gel). In the beginning of 
the  study, the wound  size was measured with the help 
of  gauge piece by cutting it  approximately to  the size 
of the wound and then  placed over the graph paper. In 
all the patients, the wound was washed with normal 
saline and the specific agent dressing were applied 
without applying any local anaesthesia in the minor 
OT/ ward dressing  room.  Dressing was done twice 
weekly on indoor/OPD basis. In Group I (Povidone  
iodine  dressing) a povidone- iodine soaked gauge 
piece, in the II group  the rEGF gel was applied and left 
for 5 minutes and then saline moist gauge piece was 
placed over the gel and bandage was applied. In each 
group dressing was continued for 12 weeks. All the 
wounds were measured once weekly during the 
dressing  time and final measurement done at the end 
of twelve weeks with the variation of max  two days 
after exposing and cleaning wound. The difference 
between the initial and final measurement was taken 
into account for analysis of results. 
Observations 
Age distribution 
Youngest patient was 45years old and eldest was 70 
years old.   Mean age was 55 years.  
Duration of diabetes 
 Duration of type 2 diabetes mellitus varied from one 
year to twenty five years. Mean duration of diabetes 
was 7 years. Five patients were diagnosed diabetes 
mellitus when they developed ulcers. 
Sex distribution 
 Total Male patients were 45 and female patients were 
15. M: F: 3:1 Incidence was more common in males as 
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most of patients were from rural area and prone to 
trauma and secondary infections leading to diabetic 
foot ulcers as compared to females. Trauma is also 
more common in males leading to diabetic foot ulcer. 
Location of ulcer 
 In this study, the lesions developed  most commonly in 
foot in 48 patients   ( 80%) followed   by  in lower leg 
around ankle in 06 patients ( 10%)  and in 10 % of 
cases involved foot and leg both . This might be due to 
prevalence of rural populations working in agriculture 
fields, walk barefoot and neglect the early 
inflammation leads to secondary infection. 
Ulcer size 
Minimum ulcer size was 5 cm2 and maximum was 
10cm2. Mean ulcer size was 7.2 cm2. History of 
previous ulcer and amputation - forty five patients 
out of 60 (75%) had history of previous healed 
ulceration and most of them had foot ulcer 
especially at the tip of toe. 10 (16.6%) patients had 
undergone amputation previously due to diabetic foot 
leading to gangrene either in the same limb or opposite 
limb. Three of the patients included in the study had 
amputated stump with surrounding ulcer not healing 
from few month. 
Duration of ulcer 
Minimum duration of ulcer was three months and 
maximum was two years. The mean duration of ulcer 
was 4.5 months. Precipitating factors of ulcer - The 
majority (50%) of foot lesions developed after trauma 
followed by infection in this study. In 40 % cases 
ulcers developed spontaneously without any apparent 
cause noticed by the person and in 10% cases, infected 
nail bed, fissures or cracks in foot was found to be 
precipitating factor.( table no 1 ) 
 
Table 1 :showing precipitating factors of ulcers 
Precipitating factors Number of cases Percentage 
Spontaneous 24 40 
Infected nail bed/Fissure 06 10 
Trauma 30 50 
Total 60 100 
 
 
Culture and sensitivity report of the wound-  In this study out of 60 patients, culture and sensitivity report was sterile 
in 36 patients (60%).. In 14 patients (23.3%) culture report was Staphylococcus, pseudomonas in5 patient (8.3%), 
proteus in 3(5%) patients and klebsiella in 2( 3.3%). Two culture and sensitivity report came to be MRSA and one 
VRSA. (Table No 2) 
Table 2: shows culture and sensitivity report 
Culture 
report 
Cases 
Sterile 36 
Staphylococcus 14 
Pseudomonas 5 
Proteus 3 
Klebsiella 2 
Healing with dressing: Six (20%) patients on Povidone iodine dressing group showed complete wound healing. 
Twenty three (76%) patients on rEGF dressing group showed complete wound healing. Dressing with recombinant 
epidermal growth factor is the more effective than Povidone iodine dressing (P<. 001)(Table No 3).  
Table 3 : shows healing with specific dressing 
 Povidine iodine 
group 
Recombinant Epidermal  
Growth Factor (Eugraf) 
P Value 
Complete Healing 6 23 >.05 
Complete Healing 6 23 <. 001 
reduction in ulcer size > 50% 8 6  
non healing 16 1  
 
Time for complete healing – In Povidone Iodine Dressing - Average healing time for complete healing for 
completely healed ulcers was 11 weeks (SD 1.25). In  rEGF Dressing - Average healing time for complete healing 
for completely healed ulcers was 8 weeks (SD 1.50) 
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Table 4: showing time of complete healing 
Average healing time Weeks 
Povidone iodine group 11 
Recombinant epidermal growth factor group 8 
 
Results   
 
Total 60 patients were included in this study. They 
were grouped randomly in two. In one group dressing 
was done by application of Povidone- Iodine solution 
over wound and in other with recombinant epidermal 
growth factor twice daily. Debridement of the wound 
done prior to the application of dressing material if 
needed and repeated if required. All the patients with 
diabetes mellitus type 2 with  inframalleolar ulcer were 
included as per inclusion and exclusion criteria. The 
dressing was continued for 12 weeks and changes in 
the size of ulcer was noted. All the patients who 
underwent amputation during the study were excluded. 
Eight patients did not come regularly for dressing were 
also excluded.  
 
Statistical analysis   
The success of the treatment was determined by 
complete healing of the ulcer in twelve weeks of 
therapy.  All the cases which do not achieve complete 
healing were categorized in two groups depending on 
their wound healing status. One group with  more than 
50% healing and other with less than 50% healing of 
the ulcer in 12 weeks therapy. The cases with less than 
50% were considered non-healing while doing the 
calculation. The calculation done based upon null 
hypothesis. The endpoints of the comparable two 
groups at a time were done by Chi Square test and by 
calculation of odd ratio with 95 % confidence interval. 
P value < .05 was considered significant. 
 
Discussion 
 
India is the diabetic capital of the world[5]. We have 
significant number of the patients with diabetic foot 
ulcer reported to our hospital in last two years. Study 
included only patients with neuropathy, infection and 
both. 
Age and Sex Distribution  
Diabetes is the disease of old age. Mean age in our 
study  was 55 years, which correlates with the  studies 
done in India[8] but in western countries  they have 
reported the mean age around 65 years[9,10].. Diabetic 
foot complications increase with the duration of 
diabetes. The study shows recurrent ulceration and 
multiple amputations common with long standing 
diabetes[11,12]. Present study also had similar 
finding.In our study diabetic foot ulcers were seen 
more commonly in males as compared to females. 
Increase Incidence in males may be because they are 
exposed to external environment more as compared to 
females, which is prevalent in Indian society. Trauma 
is also more common in males leading to diabetic foot 
ulcer[13]. Repeated foot trauma may be due low 
socioeconomic state and barefoot especially in rural 
population as in this study, ill-fitting shoes, thorn prick 
may also be the contributing factor which was seen in 
other studies[14].The majority (50%) of foot lesions 
developed after trauma followed by infection in this 
study. In 40 % cases ulcers developed spontaneously 
without any apparent cause noticed by the person and 
in 10% cases, infected nail bed, fissures or cracks in 
foot was found to be precipitating factor. In study done 
by Khan et al, 68.33 % had history of trauma by thorn 
prick, shoe bite, nail prick, wood piece prick etc. which 
is similar to our study[15].A study  done in Nigeria by 
Andrew et al showed that spontaneous blisters (32%) is 
most common precipitating factor followed by  
puncture injury (10 %) and trauma is causative factor 
only in 7% of cases  of diabetic foot ulcers in their 
locality which may be due to different cultural  and 
personal habits[14].. Reiber et al in their study in 1999 
from among 92 study patients from Manchester and 56 
from Seattle, found that neuropathy, minor foot trauma 
and foot deformity was present in more than 63% of 
patient's causal pathways to foot ulcers[15].Incidence 
of Involvement of the Parts of the Body : In this study, 
the lesions developed  most commonly in foot ( 80%) 
followed by  in lower leg around ankle ( 10%)  and in 
10 % of cases involved foot and leg both . This might 
be due to prevalence of rural populations working in 
agriculture fields and walk barefoot and neglect the 
early inflammation.  Khan et al in 2016 in their study 
over diabetic foot ulcer found similar results. The most 
common site of lesion was toes found in 23 patients 
(38.33%) followed by dorsum of foot involved in 18 
patients (30%) and whole foot involvement found only 
in 1 patient (1.67%)[13]. 
History of previous ulcer and amputation 
 History of  healed  ulceration  and amputation are 
important risk factor for diabetic foot ulceration[16]. In 
our study 45 patients had history of previous healed 
foot ulcers and 10 patients had amputation. In the study 
done by Madar Jk et al  over diabetic foot also found 
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the incidence of recurrent ulcers and amputation was  
high in diabetes patients 71% and 32.9% 
respectively[17]. Duration of ulcer – Chronic wound in 
diabetic patients  a common  challenging problem as 
these ulcers often display suboptimal wound healing 
due to association with neuropathy and poor blood 
supply. These wounds will never heal unless  the 
underlying disease and cause will be addressed 
properly. The early recognition of the high-risk patients 
and timely treatment may prevent foot ulcers, save 
limbs, potentially save lives, and improve patient 
QOL[18].These individuals often have a history of 
previous foot ulcer or lower limb minor or major 
amputation. The mean duration of ulcer in the present 
study was 4.5 months.  
Etiology of ulcer  
In this study, the lesions developed  most commonly in 
foot in 48 patients ( 80%) followed by  in lower leg 
around ankle in 06 patients ( 10%)  and in 10 % of 
cases involved foot and leg both. Peripheral neuropathy 
was present in 60% of the patients with diabetic foot 
ulcers in all patients who had previous amputation. The 
pathological process was started  in the inter digital 
spaces of toes in 06 patients in this study( 10%). 
Traumatic ulcers most commonly started at tip of the 
toe due to mino  injuries occurred during agriculture 
work and spread proximally due to inadequate 
treatment and infection control. Fifteen patients  (25%) 
patients had  deep  ulcers on the heel and on plantar 
aspect at the level of head of first metatarsal and were 
associated with sensory loss in the foot. Risk factors 
for development of chronic wound in diabetic patients 
include peripheral neuropathy, peripheral vascular 
disease, limited joint mobility, foot deformities leading 
to abnormal foot pressures, minor trauma and  history 
of previous ulceration or amputation[14].Many studies 
have also reported the combination of similar factors in 
patients with diabetic foot ulcers[16,19,20]. 
Bacteriology of diabetic foot  
Diabetic foot is a frequent complication in patients 
with diabetes mellitus and the risk of this complication 
increases with duration of diabetes mellitus. Diabetic 
polyneuropathy is one of the commonly associated risk 
factor for development of diabetic foot which later on 
complicated by superadded bacterial and fungal 
infection and if not treated promptly may lead to 
amputation of the limb( Shankar et al). These 
infections  are frequently polymicrobial[21]. . On 
culture in this study most of the culture reports are 
sterile(60 %) which might be due to the cases treated 
previously by multiple antibiotics for longer duration. 
Forty percent of wound culture had grown micro 
organism out of which 50 % are polymicrobial. 
Staphylococcus was the most commonly grown micro 
organism in 14 cases (58%) followed by pseudomonas 
in 5 patients(20.88%), proteus in 3 patient and 
klebsiella in 2 cases. Md Shakeel  and Arshiya 
Taranum in their study over 50 cases also found 
Staph.aureus was the most common organism isolated 
from diabetic foot infections[22]  Shankar et al in 2005 
in their study also found that diabetic foot infections 
are polymicrobial in 68 % of cases. But in their study 
they found  gram-negative bacteria (57.6%) were more 
commonly isolated than gram positive organism 
(42.3%), [23] The most frequent bacterial isolates 
were Pseudomonasaeruginosa, Staphylococcus aureus, 
coagulase-negative staphylococci (CONS), and 
Enterobacteriaceaes.  About 44% of P. aeruginosa  
were multi-drug-resistant, and MRSA was recovered 
on eight occasions (10.3%). Ramakant et al in their 
study found that the most common pathogens in the 
first culture were Pseudomonas aeruginosa (20.1%), 
Staphylococcus aureus (17.2%) and Escherichia coli 
(16.3%)[24].Seesdharan et al21 in their study, out of the 
total samples, 44.3% were monomicrobial and 55.7% 
were polymicrobial. Gram negative pathogens were 
predominant (58.5%). Seven of the total isolates were 
fungal; 0.7% showed pure fungal growth and 1.7% was 
mixed, grown along with some bacteria. The most 
frequently isolated bacteria were Staphylococcus 
aureus (26.9%), followed by Pseudomonas aeruginosa 
(20.9%)Dressings of diabetic foot ulcers are one 
important factor in the management of this patient 
group but in addition to dressing,  good glycemic 
control, pressure reduction, appropriate antibiotic 
therapy and surgical debridement of the wound 
debridement is very important in healing of the wound 
and prevention of amputation of the limb. The use of 
anti microbial dressing may enhances the wound 
healing in diabetic foot ulcers as compared to non anti 
microbial dressings[25].  In this study 6 (20%) patients 
on Povdone- Iodine dressing shows complete wound 
healing and 23 (6.6%) patients on rEGF dressing shows 
complete wound healing. Dressing with recombinant 
human epidermal growth factor in chronic diabetic foot 
ulcers is the significantly effective in wound healing as 
comparison to Povidone- Iodine dressings (P<. 001). 
Singla et al in their study[26] on 25 patients found that 
the application of recombinant EGF shortens the 
wound healing time significantly and the mean closure 
was significantly higher in the EGF group as compared 
with placebo. The treatment with  rEGF had  an 
advantage concerning complete wound closure and the 
time to complete wound healing in many RCT, cost 
effective analysis and meta analysis included in the 
study done by Buchberger et al[27].  In 2012 study 
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done by Singla et al also reported better results with 
recombinant epidermal factor. 
 
Conclusion 
 
 In conclusion, this study supports the application of  
recombinant EGF application over  chronic diabetic 
foot ulcers  of size 5 to 10 cm2 which is adequately 
debrided surgically, in addition to good foot care with a 
multidisciplinary team approach, enhances diabetic 
ulcer wound healing and significantly reduces the 
wound healing time as compared to Povidone- Iodine 
dressing. Further study is required to define the optimal 
dose and frequency of application of recombinant EGF 
over diabetic foot wound. 
 
What this study add to existing knowledge   
 After the eighth week of dressing, 80 % of the patients 
showed complete response to EGF application whereas 
in control group only 35 % of the patients showed 
complete response.EGF binds to its corresponding 
receptor on epidermal cell and fibroblast cell surface 
membranes in order to build collagenous tissue, and 
accelerate the generation of wound granulation and 
epithelial tissues, which accelerate the wound healing 
process[28]. It also stimulates wound matrix 
transformation, granulation tissue cell repopulation and 
angiogenesis evidenced on histological examination of 
the wound. Epidermal growth factor intralesional 
infiltrations can prevent amputation in patients with 
advanced diabetic foot wounds.[29] 
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